ASDS has acquired 50% of BR Pharmaceuticals

 

A YORKSHIRE-based pharmaceutical products firm is planning to make acquisitions after joining forces with one of the largest family businesses in the Middle Eastern state of Jordan.


BR Pharmaceuticals is poised to increase its global sales, after Phillip Byrne, the company’s managing director and owner, signed a deal which gives a 50 per cent stake in the business to Omar Abu Sheikha.

Mr Abu Sheikha owns a pharmaceutical and healthcare distribution business which operates across the Middle East; a rapidly growing retail pharmacy chain, as well as the largest money exchange business in Amman, the capital of Jordan.

According to Mr Byrne, BR, which has 27 staff and a £4m turnover, has “got its eye on a couple of companies”.

“We’re not here to stand still,” said Mr Byrne, who established the company in 1996.